subject area of A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191 Academic Article Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Academic Article
